Supplementary Table S4 from NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer
收藏NIAID Data Ecosystem2026-05-16 收录
数据链接：
官方服务：
资源简介：
This table shows the statistical analysis of significantly changed genes and pathways by treatment with anastrozole alone and by the addition of palbociclib.
创建时间：
2017-08-01
